Current Assets
Work in process
Vertex Pharmaceuticals Work in process increased by 3.9% to $1.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.0%, from $901.2M to $1.24B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 49.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2015
Last reportedQ1 2026May 5, 2026
Parent metricInventories
Metric ID:
inv_work_in_progressHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $182.66M | $192.65M | $224M | $205.8M | $236.6M | $229.3M | $260.7M | $341.1M | $398.9M | $498.3M | $525.1M | $601.8M | $657.6M | $750.1M | $768.8M | $901.2M | $1.06B | $1.1B | $1.2B | $1.24B |
| QoQ Change | — | +5.5% | +16.3% | -8.1% | +15.0% | -3.1% | +13.7% | +30.8% | +16.9% | +24.9% | +5.4% | +14.6% | +9.3% | +14.1% | +2.5% | +17.2% | +18.0% | +3.1% | +9.2% | +3.9% |
| YoY Change | — | — | — | — | +29.5% | +19.0% | +16.4% | +65.7% | +68.6% | +117.3% | +101.4% | +76.4% | +64.9% | +50.5% | +46.4% | +49.8% | +61.7% | +46.1% | +55.7% | +38.0% |
| % of Inventories | 56.8% | 57.8% | 63.4% | 60.7% | 64.3% | 59.1% | 56.6% | 63.7% | 66.1% | 72.4% | 71.1% | 74.0% | 71.9% | 69.5% | 63.8% | 66.3% | 70.9% | 67.4% | 71.0% | 70.4% |
| Share Change | — | +1.0pp | +5.7pp | -2.7pp | +3.6pp | -5.3pp | -2.5pp | +7.1pp | +2.4pp | +6.3pp | -1.3pp | +2.9pp | -2.1pp | -2.4pp | -5.7pp | +2.5pp | +4.7pp | -3.6pp | +3.6pp | -0.6pp |
Range$182.66M – $1.24B
CAGR+49.7%
Avg YoY Growth+56.7%
Median YoY Growth+53.1%
Current Streak14 quarters growth
Work in process at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's work in process?
- Vertex Pharmaceuticals (VRTX) reported work in process of $1.24B in Q1 2026.
- How has Vertex Pharmaceuticals's work in process changed year-over-year?
- Vertex Pharmaceuticals's work in process increased by 38.0% year-over-year, from $901.2M to $1.24B.
- What is the long-term trend for Vertex Pharmaceuticals's work in process?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's work in process has grown at a 49.3% compound annual growth rate (CAGR), from $161.32M to $1.2B.